(Q47563772)

English

A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects

scientific article published on 5 May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

Wolfram Samlowski

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

Salvatore Cuzzocrea

3

object named as

Salvatore Cuzzocrea

1 reference

Europe PubMed Central

4 February 2018

author name string

Ryan Petersen

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

Heather Macarthur

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

Damali Burton

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

John R McGregor

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

Daniela Salvemini

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

language of work or name

0 references

publication date

5 May 2003

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

Nature Medicine

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

750-755

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

https://scigraph.springernature.com/pub.10.1038/nm874

0 references

Human interleukin 2: molecular biology, physiology and clinical possibilities

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Vascular leak syndrome associated with interleukin-2: chest radiographic manifestations

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Cardiorespiratory effects of immunotherapy with interleukin-2.

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Biochemical and toxicological properties of the oxidation products of catecholamines

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Histamine in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Natural killing of tumor cells by human peripheral blood cells. Suppression of killing in vitro by tumor-promoting phorbol diesters

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Increased superoxide anion production by immunologically activated and chemically elicited macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation

1 reference

https://api.crossref.org/works/10.1038%2FNM874

21 January 2018

The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral bloo

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic action of gamma interferon and catalase to reverse the suppressive effect of peritoneal macrophages on concanavalin A-induced lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Catalase and lipopolysaccharide enhance proliferation in the rat mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor-mediated activation of murine peritoneal macrophages by antithrombin III acts as a costimulatory signal for nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice

1 reference

https://api.crossref.org/works/10.1038%2FNM874

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12730689

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47563772&oldid=2159707662"